Adjusted EBITDA1 of $5.0 million (25% increase from 2024) for the year ended December 31, 2025;
Generated income from operations of $1.8 million, representing a turnaround from a loss of $1.2 million in 2024;
Rapid scale-up of the Cascadia Facility with first harvests completed in February 2026.
VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV:ROMJ) (OTCQX:ROMJF) ("Rubicon Organics" or the "Company"), Canada's leading premium licensed producer focused on cultivating and selling premium and super-premium cannabis products, announces it has reported its financial results for the year ended December 31, 2025. All financial information in this press release is reported in Canadian dollars, unless otherwise noted.
"In a milestone year, we delivered record revenues, expanded our genetic and market share leadership, and completed one of the industry's fastest integrations with the Cascadia acquisition," said CEO Margaret Brodie. "As we enter 2026, we are operating from our strongest foundation to date. Cascadia is now fully planted and early harvests are complete. We expect this expanded supply to support both domestic and international growth, underpinning meaningful improvements in margin, adjusted EBITDA, and cash flow in the second half of 2026. We remain deeply focused on disciplined execution and on delivering the highest-quality cannabis from the Canadian market."
2025 Highlights:
For the twelve months ended December 31, 2025
Net revenue of $59.5 million (22% increase from 2024)
Gross profit before fair value adjustments of $19.5 million (27% increase from 2024)
Achieved Adjusted EBITDA1 of $5.0 million
Profit from operations of $1.8 million and net income of $1.1 million
#12 premium licensed producer in Canada, driven by 1964 Supply Co.™, the leading premium brand by sales2
Industry recognition winning 7 prestigious awards including Budtender Choice, and Brand of the Year for 1964 Supply Co.™
Wildflower™ is the #22 topical brand in Canada with market share of 25.9%2
18% 2 national market share of premium vapes
Acquired, modified, and ramped up Cascadia cultivation facility with currently rated capacity of 4,500 kgs of premium quality cannabis, and first harvests achieved in February 2026
Closed a non-brokered private placement offering for aggregate gross proceeds of approximately $4.5 million
Secured a $3 million long-term capital loan at interest rate of 6.79% for 5 years over a 10-year amortization period.
For the three months ended December 31, 2025 ("Q4 2025")
Net revenue of $16.5 million (16% increase from Q4 2024)
Gross profit before fair value adjustments of $5.3 million (4% increase from Q4 2024)
Achieved Adjusted EBITDA1 of $1.2 million
#12 premium licensed producer in Canada with 8.0%2 of the premium market
#12 premium vape in Canada with a market share of 18.7%2.
________________1 Adjusted EBITDA is a non-GAAP measure that is calculated as earnings (losses) from operations before interest, tax, depreciation and amortization, share-based compensation expense, fair value changes, and pre-revenue startup costs. See Non-GAAP Financial Measures for details on the Adjusted EBITDA calculation.2 Hifyre data for the three and twelve months ended December 31, 2025
2025 Results of Operations($000s)
For the year ended:
December 31,2025
December 31,2024
Net revenue
$
59,450
$
48,696
Cost of Sales
39,979
33,393
Gross profit before fair value adjustments
19,471
15,303
Fair value adjustments to cannabis plants, inventory sold, and other charges
2,666
117
Gross profit
$
22,137
$
15,420
As at:
Cash and cash equivalents
$
3,989
$
9,857
Working capital
$
23,643
$
19,945
Subsequent Sales & Operational Highlights
Cascadia completed its first harvests on February 19th, 2026. With the facility fully planted, management expects monetization in late Q2 2026, with production quality projected to reach flagship-brand standards by mid-2026. The Company is also anticipating the results of a GACP audit and its related certification, which we expect to receive in the coming months.
2026 Outlook
Leveraging Our New Scale
Demand for our flower products has consistently exceeded our available supply. We are building the teams, systems, and infrastructure needed to support the next phase of growth. With the Cascadia facility now licensed and fully operational, 2026 marks a pivotal year for Rubicon to address these supply constraints. The combined annual production capacity of 15,500 kg across our two complementary facilities, the Pacifica greenhouse and the Cascadia indoor facility, positions us well to meet growing domestic ...
